------------------------------------------------------------
[link removed]


** A Resource Roundup – Including a Recent Webinar on Trans Inclusion!
------------------------------------------------------------
Thursday, February 2

Dear Advocate,

We are only a month into the New Year and so much has happened in HIV prevention. Below are links to important resources on the latest developments.

Opinion Piece: The Fight to Decriminalize Sex Work in South Africa

South Africa-based AVAC Fellow, Liyema Synomo ([link removed]) published an opinion piece in Health-e News, Decriminalization of sex work can help prevent HIV ([link removed]) , which unpacks the reasons for reforming South Africa’s outdated legislation that criminalizes “sex work” and legitimizing and recognizing sex work as work. AVAC’s Cindra Feuer then authored a blog post sharing AVAC’s support of possible reform: Decriminalization of Sex Work Prevents HIV: South Africa could overturn its outdated laws ([link removed]) .


Publication: New Lancet HIV Publication Evaluates the Future of Injectable CAB for PrEP

The HIV Modelling Consortium along with representatives of AVAC and a number of partners recently published a modelling study in The Lancet HIV. The new study, Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a ([link removed](22)00365-4/fulltext) modelling ([link removed](22)00365-4/fulltext) study ([link removed](22)00365-4/fulltext) here ([link removed](22)00365-4/fulltext) , analyzes the potential benefits and risks from scaling up CAB for PrEP, with important implications for advocacy.


Mosaico Trial and What’s Next in HIV Vaccine Research

AVAC co-hosted with the HVTN ([link removed]) the webinar, Where Are We Now and What's Next in HIV Vaccine R&D. A link to the recording is here ([link removed]) . On the webinar, the group shared details about the Mosaico HIV vaccine trial, which found no efficacy, including characteristics of the 3,800 participants, Mosaico’s approach to its PrEP, and community input throughout the trial. For more insights, check out these articles: The Only Late-Stage HIV Vaccine Study (Mosaico) Just Tanked. What’s Next? ([link removed]) in The Body and Why inventing a vaccine for AIDS is tougher than
for COVID ([link removed]) in NPR’s Goats and Soda.

Webinar: Trans Inclusion and TG Scorecard

The Choice Agenda ([link removed]) hosted its first webinar of 2023, Trans Inclusion: Charting HIV Research into the Future: A Manifesto and Scorecard for Advocates and Researchers with Leigh Ann van der Merwe, Brian Minalga, and AVAC’s own Cindra Feuer joined by over 80+ participants. Panelists unpacked the No Data No More manifesto ([link removed]) and discussed preliminary findings from the TG scorecard, which looked at transgender representation in clinical trials over time. Watch the full recording of the webinar ([link removed]) and check out the slides ([link removed]) and resources here ([link removed]) .


Best,
AVAC

P.S. As a reminder, there are three upcoming webinars this month:
* The Power Of PrEP ([link removed]) : Pleasure and Prevention In The Black Community on Tuesday, February 7 at 2:00 PM ET from the PrEP in Black America Coalition ([link removed]) on National Black HIV/AIDS Awareness Day
* Ready, Set, CROI 2023 - Prepare for the 30th Year of CROI ([link removed]) on Monday, February 13 at 9:00 AM ET / 2:00 PM GMT
* Decolonizing Global Public Health – What Will it Take to Dismantle Racism and White Supremacy? ([link removed]) on Thursday, February 16 at 9:00am ET / 2:00 pm GMT


============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])